Identification of Sorafenib as a Treatment for Type 1 Diabetes

Th1 cell activation is considered a key mediator of the pathogenesis of type 1 diabetes. Targeting IL-12-induced Th1 cell differentiation seems to be an effective way to block the development of type 1 diabetes. However, given the critical function of Th1 in the immune system, the potential side eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Qin, Song, Jianfeng, Wang, Dandan, Sun, Xiaoxiao, Xiao, Yalun, Zhang, Haowei, Xiao, Yang, Zhou, Zhiguang, Deng, Tuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886732/
https://www.ncbi.nlm.nih.gov/pubmed/35242127
http://dx.doi.org/10.3389/fimmu.2022.740805

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886732/
https://www.ncbi.nlm.nih.gov/pubmed/35242127
http://dx.doi.org/10.3389/fimmu.2022.740805

Ejemplares similares